Dr. Saravanan Thiagarajan, MD

Dr. Thiagarajan practices at Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System.

Dr. Thiagarajan's NPI, 1154639839, was assigned on September 16, 2010. Dr. Thiagarajan holds Louisiana license MD.207573.

Dr. Thiagarajan's primary practice is Ochsner Medical Center - Baton Rouge, at 17000 Medical Center Dr, Baton Rouge, LA 70816 in E. Baton Rouge Parish. The practice phone is (225) 752-2470.

Dr. Thiagarajan's primary practice is Ochsner Medical Center - Baton Rouge in Baton Rouge, Louisiana, part of Ochsner Health System. Dr. Thiagarajan is also affiliated with Ochsner Medical Center - New Orleans. The medical group on file is Ochsner Health. Dmand AI also links Dr. Thiagarajan to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thiagarajan practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Thiagarajan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Thiagarajan's licenses on file in 2 states: Louisiana and Ohio.

CMS data shows 709 Medicare services from Dr. Thiagarajan across 6 procedure codes in 2024, for 333 Medicare patients. Medicare paid $47,539 for them.

CMS counts 333 Medicare patients who saw Dr. Thiagarajan in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have arthritis, and 74% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thiagarajan's median patient age at 70, with 82% women.

In 2024, Dr. Thiagarajan wrote 6,412 Medicare Part D claims for 846 patients. 82% of them were for generic drugs. CMS names the drug for 6,029 of them, across 78 drugs with 11 or more claims each, at $5,522,141 in total drug cost. In 2023, CMS named 5,362 claims across 69 drugs.

Dr. Thiagarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thiagarajan as offering telehealth.

Dmand AI links 4 papers to Dr. Thiagarajan. The most frequent topics are Creatine Kinase, Myositis and Alanine Transaminase. Dr. Thiagarajan has published most often in J Clin Rheumatol. Dr. Thiagarajan's most frequent co-authors are Joel A. Block, MD, Bala Hota, MD and Augustine M. Manadan, MD.

CMS Open Payments shows 160 general payments to Dr. Thiagarajan from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Horizon Pharma plc paid the most, $1,708.